These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 15696499)
1. Analysis of clinical data with breached blindness: by Shein-Chung Chow and Jun Shao Statistics in Medicine 2004; 23:1185-1193. Ganju J Stat Med; 2005 Mar; 24(5):819-21; author reply 821-2. PubMed ID: 15696499 [No Abstract] [Full Text] [Related]
2. Analysis of clinical data with breached blindness. Hemilä H Stat Med; 2006 Apr; 25(8):1434-7; author reply 1437-8. PubMed ID: 16572386 [No Abstract] [Full Text] [Related]
3. Analysis of clinical data with breached blindness. Chow SC; Shao J Stat Med; 2004 Apr; 23(8):1185-93. PubMed ID: 15083477 [TBL] [Abstract][Full Text] [Related]
4. How do we know what we know? The randomized controlled trial revisited. Heaney RP J Bone Miner Res; 1991 Feb; 6(2):103-5. PubMed ID: 2028831 [No Abstract] [Full Text] [Related]
5. Assuring that double-blind is blind. Perlis RH; Ostacher M; Fava M; Nierenberg AA; Sachs GS; Rosenbaum JF Am J Psychiatry; 2010 Mar; 167(3):250-2. PubMed ID: 20194487 [No Abstract] [Full Text] [Related]
6. A sequential trial of pain killers in arthritis: issues of multiple comparisons with control and of interval-censored survival data. Whitehead J; Thomas P J Biopharm Stat; 1997 Jul; 7(3):333-53. PubMed ID: 9252829 [TBL] [Abstract][Full Text] [Related]
10. Blinded assessment of treatment effects utilizing information about the randomization block length. Miller F; Friede T; Kieser M Stat Med; 2009 May; 28(12):1690-706. PubMed ID: 19340815 [TBL] [Abstract][Full Text] [Related]
11. Stopping trials for efficacy: an almost unbiased view. Goodman SN Clin Trials; 2009 Apr; 6(2):133-5. PubMed ID: 19342465 [No Abstract] [Full Text] [Related]
13. The blind leading the blind: use and misuse of blinding in randomized controlled trials. Miller LE; Stewart ME Contemp Clin Trials; 2011 Mar; 32(2):240-3. PubMed ID: 21070890 [TBL] [Abstract][Full Text] [Related]
14. Comments on "Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II Study)" by Dr Thase and colleagues. Rifkin AE J Clin Psychopharmacol; 2008 Jun; 28(3):367; author reply 368. PubMed ID: 18480708 [No Abstract] [Full Text] [Related]
15. Missing data handling in chronic pain trials. Kim Y J Biopharm Stat; 2011 Mar; 21(2):311-25. PubMed ID: 21391004 [TBL] [Abstract][Full Text] [Related]
16. Blinding during data analysis and writing of manuscripts. Gøtzsche PC Control Clin Trials; 1996 Aug; 17(4):285-90; discussion 290-3. PubMed ID: 8889343 [No Abstract] [Full Text] [Related]
18. Issues in the planning and conduct of randomised trials. Bhandari M; Pape HC; Giannoudis PV Injury; 2006 Apr; 37(4):349-54. PubMed ID: 16487524 [TBL] [Abstract][Full Text] [Related]
19. Comment on 'Inference on treatment effects for targeted clinical trials under enrichment design', Jen-Pei Liu, Jr-Rung Lin, and Shein-Chung Chow; Pharmaceutical Statistics 2009; 8:356-370. Chen L; Liu YX Pharm Stat; 2012; 11(4):342; author reply 343-5. PubMed ID: 22589013 [No Abstract] [Full Text] [Related]
20. How well does blinding work in randomized controlled trials?: a counterpoint. Boehmer J; Yong P Clin Pharmacol Ther; 2009 May; 85(5):463-5. PubMed ID: 19381149 [No Abstract] [Full Text] [Related] [Next] [New Search]